We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR... Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company's only operating segment is developing and commercializing genome editing technology. Show more
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that three abstracts have been accepted for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2 | -3.6231884058 | 5.52 | 5.92 | 5.11 | 1805591 | 5.43233804 | CS |
4 | -2.09 | -28.2051282051 | 7.41 | 7.41 | 5.11 | 1700795 | 6.1792985 | CS |
12 | -1.77 | -24.9647390691 | 7.09 | 11.58 | 5.11 | 1948882 | 7.8514371 | CS |
26 | -1.33 | -20 | 6.65 | 11.69 | 5.11 | 1896532 | 8.65180841 | CS |
52 | -2.46 | -31.6195372751 | 7.78 | 11.91 | 5.11 | 1839034 | 8.65465217 | CS |
156 | -31.66 | -85.6138453218 | 36.98 | 73.025 | 5.11 | 1752738 | 18.28798297 | CS |
260 | -21.93 | -80.4770642202 | 27.25 | 99.95 | 5.11 | 1530065 | 25.57336656 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions